Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVR Anteris Technologies Global	$3.60 -1.6%	$3.57	$2.34 ▼ $8.79	$129.82M	N/A	202,023 shs	67,300 shs
LNSR LENSAR	$12.15 -0.3%	$12.86	$3.80 ▼ $17.31	$145.07M	0.5	127,560 shs	121,516 shs
PDEX Pro-Dex	$46.45 +2.1%	$45.76	$21.20 ▼ $70.26	$151.47M	0.19	46,227 shs	18,815 shs
RBOT Vicarious Surgical	$6.32 -3.8%	$8.50	$5.00 ▼ $19.00	$37.48M	1.41	30,185 shs	24,061 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVR Anteris Technologies Global	-3.17%	+2.81%	+9.25%	-18.85%	+365,999,900.00%
LNSR LENSAR	-3.18%	-2.87%	-7.02%	-11.15%	+162.15%
PDEX Pro-Dex	-2.59%	+1.70%	-14.95%	+12.76%	+110.36%
RBOT Vicarious Surgical	-0.26%	+11.20%	-32.78%	-15.71%	-6.23%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVR Anteris Technologies Global	1.8822 of 5 stars	3.5	0.0	2.7	0.0	0.6
LNSR LENSAR	1.0432 of 5 stars	2.0	1.0	3.2	2.5	0.0
PDEX Pro-Dex	2.2787 of 5 stars	2.5	1.0	3.5	1.7	1.9
RBOT Vicarious Surgical	0.5674 of 5 stars	1.0	2.0	1.4	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVR Anteris Technologies Global	3.00	Buy	$16.50	358.33% Upside
LNSR LENSAR	2.00	Hold	$15.00	23.46% Upside
PDEX Pro-Dex	3.00	Buy	$56.00	20.56% Upside
RBOT Vicarious Surgical	2.00	Hold	$7.00	10.74% Upside

Current Analyst Ratings Breakdown

Latest RBOT, LNSR, PDEX, and AVR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/13/2025	RBOT Vicarious Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.50 ➝ $7.00

(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVR Anteris Technologies Global	$2.70M	48.08	N/A	N/A	$0.67 per share	5.37
LNSR LENSAR	$53.49M	2.71	N/A	N/A	($1.93) per share	-6.30
PDEX Pro-Dex	$64.12M	2.36	$0.95 per share	48.78	$9.03 per share	5.14
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	$3.89 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVR Anteris Technologies Global	-$76.29M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	11/10/2025 (Estimated)
LNSR LENSAR	-$31.40M	-$4.21	N/A	∞	N/A	-84.49%	-737.30%	-72.60%	11/6/2025 (Estimated)
PDEX Pro-Dex	$2.13M	$2.80	16.59	22.55	N/A	14.61%	29.08%	16.19%	9/4/2025 (Estimated)
RBOT Vicarious Surgical	-$63.22M	-$10.09	N/A	N/A	N/A	N/A	-148.14%	-98.07%	11/11/2025 (Estimated)

Latest RBOT, LNSR, PDEX, and AVR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/4/2025	Q4 2025	PDEX Pro-Dex	$0.47	N/A	N/A	N/A	$17.90 million	N/A
8/12/2025	Q2 2025	RBOT Vicarious Surgical	-$2.61	-$2.23	+$0.38	-$2.23	N/A	N/A
8/11/2025	Q2 2025 TU	AVR Anteris Technologies Global	-$0.5333	-$0.58	-$0.0467	-$0.58	$0.58 million	$0.62 million
8/7/2025	Q2 2025	LNSR LENSAR	-$0.0750	-$0.15	-$0.0750	-$0.15	$16.55 million	$11.36 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
PDEX Pro-Dex	N/A	N/A	N/A	N/A	N/A
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVR Anteris Technologies Global	N/A	2.41	2.38
LNSR LENSAR	N/A	1.52	0.88
PDEX Pro-Dex	0.28	2.73	1.45
RBOT Vicarious Surgical	N/A	5.11	5.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVR Anteris Technologies Global	N/A
LNSR LENSAR	40.15%
PDEX Pro-Dex	15.28%
RBOT Vicarious Surgical	47.27%

Insider Ownership

Company	Insider Ownership
AVR Anteris Technologies Global	4.00%
LNSR LENSAR	38.52%
PDEX Pro-Dex	47.50%
RBOT Vicarious Surgical	11.99%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVR Anteris Technologies Global	138	36.06 million	34.62 million	N/A
LNSR LENSAR	110	11.94 million	7.34 million	Optionable
PDEX Pro-Dex	140	3.26 million	1.71 million	Not Optionable
RBOT Vicarious Surgical	210	5.93 million	5.22 million	No Data

RBOT, LNSR, PDEX, and AVR Headlines

Recent News About These Companies

Vicarious Surgical (NYSE:RBOT) Director Sells $18,445.10 in Stock

August 28 at 8:57 AM | insidertrades.com

Vicarious Surgical Faces Setback as Human Trials for Surgical Robot Are Delayed

August 25 at 8:39 AM | aktiencheck.deA

Donald Tang Sells 2,059 Shares of Vicarious Surgical (NYSE:RBOT) Stock

August 22, 2025 | insidertrades.com

Robotic surgery heats up with clearances and clinical trials

August 20, 2025 | crainsnewyork.comC

Vicarious Surgical (NYSE:RBOT) Given New $7.00 Price Target at Piper Sandler

August 15, 2025 | marketbeat.com

Vicarious Surgical (NYSE:RBOT) Announces Quarterly Earnings Results, Beats Expectations By $0.38 EPS

August 14, 2025 | marketbeat.com

Vicarious Surgical’s Earnings Call: Progress Amid Challenges

August 14, 2025 | msn.com

Vicarious Surgical delays robot clinical timeline

August 14, 2025 | finance.yahoo.com

Vicarious Surgical’s new CEO pushes back robot development timeline

August 14, 2025 | fiercebiotech.comF

Vicarious Surgical delays robot timeline

August 14, 2025 | finance.yahoo.com

Vicarious Surgical pushes back surgical robot timeline again

August 13, 2025 | massdevice.com

Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call Transcript

August 13, 2025 | msn.com

Vicarious Surgical Reports Improved Q2 Financials and Leadership Change

August 13, 2025 | msn.com

Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript

August 12, 2025 | seekingalpha.com

Vicarious Surgical anticipates FY25 cash burn of about $50M

August 12, 2025 | msn.com

Vicarious Surgical reports Q2 EPS ($2.23), consensus ($2.50)

August 12, 2025 | msn.com

Vicarious Surgical Reports Second Quarter 2025 Financial Results

August 12, 2025 | businesswire.com

Vicarious Surgical (NYSE:RBOT) Stock Price Down 4.4% - What's Next?

August 8, 2025 | marketbeat.com

Vicarious Surgical (RBOT) to Release Quarterly Earnings on Tuesday

August 6, 2025 | marketbeat.com

Vicarious Surgical names Stephen From as next CEO

August 2, 2025 | medtechdive.comM

Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer

July 31, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RBOT, LNSR, PDEX, and AVR Company Descriptions

Anteris Technologies Global NASDAQ:AVR

$3.60 -0.06 (-1.64%)

As of 04:00 PM Eastern

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

LENSAR NASDAQ:LNSR

$12.15 -0.04 (-0.33%)

Closing price 04:00 PM Eastern

Extended Trading

$12.14 -0.02 (-0.12%)

As of 04:11 PM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Pro-Dex NASDAQ:PDEX

$46.45 +0.95 (+2.09%)

Closing price 04:00 PM Eastern

Extended Trading

$46.68 +0.23 (+0.51%)

As of 05:41 PM Eastern

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Vicarious Surgical NYSE:RBOT

$6.32 -0.25 (-3.79%)

Closing price 03:59 PM Eastern

Extended Trading

$6.37 +0.05 (+0.78%)

As of 05:33 PM Eastern

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time